Transparency Market Research
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Published Date 06-Feb-2014
122 Page Report
Buy Now
Request Sample
Press Release Molecular Diagnostics Market in 2019: A New Market Research Report by Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
REPORT DESCRIPTION
Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market. Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html The research report on molecular diagnostics provides detailed analysis of the global market and helps in understanding the driving forces responsible for its growth. The report discusses the molecular diagnostics market on the basis of different technologies and applications. The technology segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, next generation sequencing and others. The application segment is classified into infectious diseases, blood donor screening and genomics. The genomics segmented is further classified into genetic disorders testing, oncology testing, HLA testing and pharmacogenetic testing. The infectious diseases segment is subsegmented into virology and bacteriology. The virology section of the report deals with testing of following infections namely, HIV (Human immunodeficiency virus), HPV (Human papillomavirus), HCV (Hepatitis C virus) and others. The bacteriology segment of the report is further categorized into hospital acquired infections (HAI), CT/NG (Chlamydia trachomatis and Neisseria gonorrhoeae) and others. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1783 The molecular diagnostics market has also been segmented geographically into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW), and respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global molecular diagnostics market, and future opportunities has been provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter’s five forces analysis for the molecular diagnostics market that would help in determining the degree of competition in the market. The entire section of market overview plays an important role in understanding the market on a global level. Further, the report on molecular diagnostics also provides executive summary that that will help you understand the overall market size, growth rate of various segments, geographies and competitors present in the market in a very precise manner.
Browse More Medical Devices Related Research Reports at http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html The molecular diagnostics market report also provides a highlight of the competitive landscape of the market wherein the market share analysis of the leading players in the market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the molecular diagnostics market such as Abbott Laboratories, Becton Dickinson & Company, Cepheid, Roche Diagnostics and others. Profiles of these players have been extensively analyzed on the basis of company overview, financial overview, business strategies, product portfolio and recent developments.
TABLE OF CONTENT Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Assumptions
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019) 2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)
Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Rising incidence of cancer cases 3.2.2 Aging population 3.2.3 Increase in incidence of chronic diseases 3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines 3.3 Market Restraints
3.3.1 Issues with reimbursement policies 3.4 Market Opportunities 3.4.1 Technological advancements 3.4.2 Tapping the emerging economies
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
3.5 Porter’s Five Force Analysis: Global Molecular Diagnostics Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of New Entrants 3.5.4 Threat of Substitutes 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography
Chapter 4 Molecular Diagnostics Market, by Technology 4.1 Overview 4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 4.2 Polymerase Chain Reaction (PCR) 4.2.1 Global PCR Market, 2011 – 2019 (USD Million) 4.3 Transcription Mediated Amplification (TMA) 4.3.1 Global TMA Market, 2011 – 2019 (USD Million) 4.4 Microarray 4.4.1 Global Microarray Market, 2011 – 2019 (USD Million) 4.5 Hybridization (ISH and FISH) 4.5.1 Global Hybridization Market, 2011 – 2019 (USD Million)
4.6 Next-generation sequencing 4.6.1 Global Next generation sequencing Market, 2011 – 2019 (USD Million) 4.7 Others 4.7.1 Global Others Market, 2011 – 2019 (USD Million)
Chapter 5 Global Molecular Diagnostics Market, by Applications 5.1 Overview 5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million) 5.2 Infectious Diseases 5.2.1 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million) 5.2.2 Virology 5.2.2.1 Global Virology Market, by Segments, 2011 – 2019 (USD Million) 5.2.2.2 Human immunodeficiency virus (HIV) testing 5.2.2.2.1 Global HIV testing Market, 2011 – 2019 (USD Million) 5.2.2.3 Human papillomavirus (HPV) testing 5.2.2.3.1 Global HPV testing Market, 2011 – 2019 (USD Million) 5.2.2.4 Hepatitis C virus (HCV) testing 5.2.2.4.1 Global HCV testing Market, 2011 – 2019 (USD Million) 5.2.2.5 Others 5.2.2.5.1 Global Others testing Market, 2011 – 2019 (USD Million) 5.2.3 Bacteriology 5.2.3.1 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million) 5.2.3.2 Hospital Acquired Infection (HAI) testing 5.2.3.2.1 Global HAI testing Market, 2011 – 2019 (USD Million) 5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing 5.2.3.3.1 Global CT/NG testing Market, 2011 – 2019 (USD Million)
5.2.3.4 Others 5.2.3.4.1 Global Others testing Market, 2011 – 2019 (USD Million) 5.3 Genomics 5.3.1 Global Genomics Market, by Segments, 2011 – 2019 (USD Million) 5.3.2 Genetic testing for inherited disorders 5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD Million)
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
5.3.3 Human Leukocyte Antigen (HLA)testing 5.3.3.1 Global HLA testing Market, 2011 – 2019 (USD Million) 5.3.4 Pharmacogenetics testing 5.3.4.1 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million) 5.3.5 Oncology testing 5.3.5.1 Global Oncology testing Market, 2011 – 2019 (USD Million) 5.4 Blood Donor Screening 5.4.1 Global Blood donor screening testing Market, 2011 – 2019 (USD Million) 5.5 Others 5.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
Chapter 6 Global Molecular Diagnostics Market, by Geography 6.1 Overview 6.1.1 Global Molecular Diagnostics Market, by Geography, 2011 – 2019 (USD Million) 6.2 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %) 6.3 North America 6.3.1 North America Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.3.2 North America Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 6.4 Europe 6.4.1 Europe Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million) 6.4.2 Europe Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 6.5 Asia-Pacific 6.5.1 Asia Pacific Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million) 6.5.2 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million) 6.6 RoW 6.6.1 RoW Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million) 6.6.2 RoW Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
Chapter 7 Global Molecular Diagnostics Market Share Analysis 7.1 Market Share Analysis by Key Players of Global Molecular Diagnostics Market 7.1.1 Global Molecular Diagnostics Market Share Analysis, by Key Players, 2012 (%) 7.1.2 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market
Chapter 8 Recommendations 8.1 Market Strategies for Success 8.1.1 Long term contracts with healthcare service providers 8.1.2 Investing in emerging economies such as China, India and Russia 8.1.3 Broadening of distribution network
Chapter 9 Company Profiles 9.1 Abbott Laboratories 9.1.1 Company Overview 9.1.2 Financial Overview
9.1.3 Product Portfolio 9.1.4 Business Strategies 9.1.5 Recent Developments 9.2 Becton Dickinson & Company 9.2.1 Company Overview 9.2.2 Financial Overview 9.2.3 Product Portfolio 9.2.4 Business Strategies 9.2.5 Recent Developments
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html 9.3 bioMerieux 9.3.1 Company Overview 9.3.2 Financial Overview 9.3.3 Product Portfolio 9.3.4 Business Strategies 9.3.5 Recent Developments 9.4 Bio-Rad 9.4.1 Company Overview 9.4.2 Financial Overview 9.4.3 Product Portfolio 9.4.4 Business Strategies 9.4.5 Recent Developments 9.5 Cepheid 9.5.1 Company Overview 9.5.2 Financial Overview 9.5.3 Product Portfolio
9.5.4 Business Strategies 9.5.5 Recent Developments 9.6 Danaher Corporation (Beckman Coulter) 9.6.1 Company Overview 9.6.2 Financial Overview 9.6.3 Product Portfolio 9.6.4 Business Strategies 9.6.5 Recent Developments 9.7 F. Hoffmann-La Roche Ltd. 9.7.1 Company Overview 9.7.2 Financial Overview 9.7.3 Product Portfolio 9.7.4 Business Strategies 9.7.5 Recent Developments 9.8 Hologic, Inc. (Gen-Probe) 9.8.1 Company Overview 9.8.2 Financial Overview 9.8.3 Product Portfolio 9.8.4 Business Strategies 9.8.5 Recent Developments 9.9 Myriad Genetics, Inc. 9.9.1 Company Overview 9.9.2 Financial Performance 9.9.3 Product Portfolio 9.9.4 Business Strategies 9.9.5 Recent Developments
9.10 Novartis International AG 9.10.1 Company Overview 9.10.2 Financial Overview 9.10.3 Product Portfolio 9.10.4 Business Strategies 9.11 Qiagen 9.11.1 Company Overview 9.11.2 Financial Overview 9.11.3 Product Portfolio 9.11.4 Business Strategies 9.11.5 Recent Developments 9.12 Quest Diagnostics, Inc. 9.12.1 Company Overview 9.12.2 Financial Overview 9.12.3 Product Portfolio 9.12.4 Business Strategies 9.12.5 Recent Developments
Browse the Molecular Diagnostics Market Research Report with complete TOC at http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
9.13 Siemens AG 9.13.1 Company Overview 9.13.2 Financial Overview 9.13.3 Product Portfolio 9.13.4 Business Strategies 9.13.5 Recent Developments
9.14 Thermo Fisher Scientific 9.14.1 Company Overview 9.14.2 Financial Overview 9.14.3 Product Portfolio 9.14.4 Business Strategies 9.14.5 Recent Developments.
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com/